← Leaderboards
Suzette M Evans
New York State Psychiatric Institute
$16,643,423
Attributed
$20,110,727
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$20,110,727 · 11
By mechanism
R01$19,972,032 · 10
U54$138,695 · 1
Top collaborators
- Gillinder I. Bedi7 shared
- Richard W Foltin6 shared
Most similar at New York State Psychiatric Institute
Same institution · by research overlap
- Margaret Haney$20,571,313
- Sandra D. Comer$36,146,642
- Anissa Abi-Dargham$23,437,686
Others in their field
Top investigators on “Female”
- Philip J Disaia · University Of California Irvine$140,003,514
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$103,542,269
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,372,214
- Myron S Cohen · Family Health International$101,800,876
- Walter John Curran · Thomas Jefferson University$57,608,324
- Gregory S Boebinger · Florida State University$55,673,680
Research focus
FemaleBehavioralMaleSelf AdministrationBasePharmaceutical PreparationsMenstrual CycleDrug UsageReinforcerLaboratoriesCocaineResponseBehavioral /Social Science Research TagSex CharacteristicsSmokeReportingAffectWomanSocialQuestionnairesRecording Of Previous EventsLeadPlayDrug Abuse
Grant awards (46)
Antecedents and Consequences of Cocaine Taking: Impact of Oxytocin$620,238
R01 · FY2022 · DA · contact PI
Antecedents and Consequences of Cocaine Taking: Impact of Oxytocin$620,927
R01 · FY2021 · DA · contact PI
Neurobehavioral Mechanisms of Choices to Smoke Cannabis in Cannabis Use Disorder$586,571
R01 · FY2021 · DA · contact PI
Neurobehavioral Mechanisms of Choices to Smoke Cannabis in Cannabis Use Disorder$586,571
R01 · FY2020 · DA · contact PI
Antecedents and Consequences of Cocaine Taking: Impact of Oxytocin$579,018
R01 · FY2020 · DA · contact PI
Neurobehavioral Mechanisms of Choices to Smoke Cannabis in Cannabis Use Disorder$586,571
R01 · FY2019 · DA · contact PI
Neurobehavioral Mechanisms of Choices to Smoke Cannabis in Cannabis Use Disorder$117,816
R01 · FY2019 · DA · contact PI
Antecedents and Consequences of Cocaine Taking: Impact of Oxytocin$592,695
R01 · FY2018 · DA · contact PI
Neurobehavioral Mechanisms of Choices to Smoke Cannabis in Cannabis Use Disorder$586,571
R01 · FY2018 · DA · contact PI
Neurobehavioral Mechanisms of Choices to Smoke Cannabis in Cannabis Use Disorder$117,816
R01 · FY2018 · DA · contact PI
Antecedents and Consequences of Cocaine Taking: Impact of Oxytocin$680,047
R01 · FY2017 · DA · contact PI
Neurobehavioral Mechanisms of Choices to Smoke Cannabis in Cannabis Use Disorder$542,099
R01 · FY2017 · DA · contact PI
Preclinical Synthetic Cannabinoid Vapor Inhalation: Acute and Chronic Effects$717,669
R01 · FY2016 · DA · contact PI
Stress-Induced Marijuana Self-Administration: Role of Sex and Oxytocin$483,455
R01 · FY2016 · DA · contact PI
Stress-Induced Marijuana Self-Administration: Role of Sex and Oxytocin$481,014
R01 · FY2015 · DA · contact PI
Pilot Project Core$72,249
U54 · FY2015 · DA · contact PI
Pilot Project Core$66,446
U54 · FY2014 · DA · contact PI
Stress-Induced Marijuana Self-Administration: Role of Sex and Oxytocin$504,696
R01 · FY2013 · DA · contact PI
Sex Differences in Stress & Impulsivity in Cocaine Abusers$499,998
R01 · FY2011 · DA · contact PI
Vulnerability to Anxiolytic Abuse in Women$493,370
R01 · FY2010 · DA · contact PI
Sex Differences in Stress & Impulsivity in Cocaine Abusers$507,376
R01 · FY2009 · DA · contact PI
Vulnerability to Anxiolytic Abuse in Women$484,101
R01 · FY2009 · DA · contact PI
Progesterone Treatment for Cocaine-Dependent Women$355,835
R01 · FY2009 · DA · contact PI
Sex Differences in Stress & Impulsivity in Cocaine Abusers$478,798
R01 · FY2008 · DA · contact PI
Vulnerability to Anxiolytic Abuse in Women$468,620
R01 · FY2008 · DA · contact PI
Progesterone Treatment for Cocaine-Dependent Women$352,210
R01 · FY2008 · DA · contact PI
Sex Differences in Stress & Impulsivity in Cocaine Abusers$496,778
R01 · FY2007 · DA · contact PI
Vulnerability to Anxiolytic Abuse in Women$480,542
R01 · FY2007 · DA · contact PI
Progesterone Treatment for Cocaine-Dependent Women$355,820
R01 · FY2007 · DA · contact PI
Vulnerability to Anxiolytic Abuse in Women$483,220
R01 · FY2006 · DA · contact PI
Effects of Smoked Heroin Across the Menstrual Cycle$279,177
R01 · FY2005 · DA
VULNERABILITY TO ANXIOLYTIC ABUSE IN WOMEN$460,533
R01 · FY2004 · DA
Effects of Smoked Heroin Across the Menstrual Cycle$276,342
R01 · FY2004 · DA
COCAINE'S EFFECTS ACROSS THE MENSTRUAL CYCLE$266,415
R01 · FY2004 · DA
MEDICATIONS DEVELOPMENT FOR ALCOHOL ABUSE: NMDA AGENTS$579,508
R01 · FY2003 · AA
VULNERABILITY TO ANXIOLYTIC ABUSE IN WOMEN$447,152
R01 · FY2003 · DA
Effects of Smoked Heroin Across the Menstrual Cycle$298,391
R01 · FY2003 · DA
COCAINE'S EFFECTS ACROSS THE MENSTRUAL CYCLE$266,415
R01 · FY2003 · DA
MEDICATIONS DEVELOPMENT FOR ALCOHOL ABUSE: NMDA AGENTS$558,864
R01 · FY2002 · AA
VULNERABILITY TO ANXIOLYTIC ABUSE IN WOMEN$434,157
R01 · FY2002 · DA
COCAINE'S EFFECTS ACROSS THE MENSTRUAL CYCLE$266,415
R01 · FY2002 · DA
MEDICATIONS DEVELOPMENT FOR ALCOHOL ABUSE: NMDA AGENTS$538,829
R01 · FY2001 · AA
VULNERABILITY TO ANXIOLYTIC ABUSE IN WOMEN$421,538
R01 · FY2001 · DA
COCAINE'S EFFECTS ACROSS THE MENSTRUAL CYCLE$266,415
R01 · FY2001 · DA
VULNERABILITY TO ANXIOLYTIC ABUSE IN WOMEN$445,631
R01 · FY2000 · DA
MEDICATIONS DEVELOPMENT FOR ALCOHOL ABUSE: NMDA AGENTS$305,808
R01 · FY2000 · AA